Articles tagged with Pancreatic Cancer
A cohort study found that higher insulin concentrations and insulin resistance were associated with an increased risk of pancreatic cancer in male smokers. The study suggests that lifestyle changes to decrease glucose and insulin levels may help prevent pancreatic cancer development.
Researchers developed a new treatment that reverses traditional treatment steps, reducing tumor size and increasing surgical removal options. The treatment has shown significant success in shrinking tumors, with no progression or recurrence observed after surgery.
Researchers have developed an immune-boosting vaccine that combines with surgery and chemotherapy to treat pancreatic cancer. Early results show improved survival rates, surpassing previous studies, and the team hopes to refine the vaccine's targets through further analysis.
Researchers found that vasostatin, a protein gene incorporated into an adenovirus vector, effectively blocks the formation of new blood vessels and curbs tumour growth in mice with pancreatic cancer. This approach may represent a promising therapeutic option for malignancy with a poor prognosis.
A phase III clinical trial found that combining gemcitabine with capecitabine significantly improves overall survival for patients with locally advanced or metastatic pancreatic cancer. The combination of treatments resulted in a median survival of 7.4 months compared to 6 months with gemcitabine alone.
Researchers found a possible genetic link between cystic fibrosis gene mutations and young-onset pancreatic cancer. The study showed that individuals carrying the CFTR gene mutation are at increased risk for pancreatitis, which may also increase the risk of developing pancreatic cancer.
Researchers found no link between breast-feeding and adult cancer risk, but high red meat consumption is associated with increased pancreatic cancer risk. A new vaccine approach may enhance tumor-specific immune response when combined with chemotherapy.
A novel screening method for pancreatic cancer has been developed by scientists at the University of Liverpool. The method analyzes genetic mutations in pancreatic juice to determine an individual's risk of developing cancer, with results ranging from a 0.1% chance to a 90% certainty.
A high-vegetable diet rich in onions, garlic, beans, and yellow vegetables was associated with a 50% reduced risk of pancreatic cancer. Fruits were also found to be protective, but to a lesser extent.
A study published in American Journal of Roentgenology found that 3D MRI can detect pancreatic cancer in patients with severe mid-abdominal pain and other symptoms. The study suggests that radiologists should look for pancreatic cancer even if the patient didn't have an examination for that purpose.
A study by Rutgers University researchers found that combining TPA, a compound from the croton plant, with all-trans retinoic acid (ATRA) effectively inhibits growth of pancreatic cancer cells. The combination also showed increased apoptosis and reduced mitosis in tumors.
Researchers found that older patients with newly diagnosed diabetes are considered a high-risk group for developing pancreatic cancer. The study, conducted by the Mayo Clinic College of Medicine, included 2,122 patients aged 50 and older who were diagnosed with diabetes between 1950 and 1995.
A new study has identified older Americans with new-onset diabetes as a high-risk group for pancreatic cancer. The research found that patients with type 2 diabetes are at a significantly higher risk of developing pancreatic cancer compared to those without the condition, highlighting the need for early detection and screening.
Researchers at Dartmouth discovered a molecule called Smad7, found in half of all human pancreatic cancers, that interferes with pathways regulating cell growth. Smad7 suppresses the function of the retinoblastoma protein, enabling cancer cells to grow unchecked and increasing metastasis.
Researchers developed a mouse model that closely mimics human pancreatic cancer at multiple levels, including clinical presentation and histological changes. The model demonstrates distinct similarities to human pancreatic cancer, including metastasis to the liver and lungs.
A combination of chemotherapy drugs showed improved overall and progression-free survival rates compared to a single drug, gemcitabine. Patients treated with the combination regimen (PEGF) had a higher percentage alive without disease after 4 months than those on standard treatment.
Metal stents have been shown to be a safe and effective treatment for bile duct obstructions caused by pancreatic cancer. The study found that 90% of patients had open stents after three months and 80% after one year, with minimal complications.
A large cohort study found that high consumption of processed meats was associated with a significant increase in pancreatic cancer risk. The study, which followed over 190,000 participants, suggests that chemical reactions during meat preparation may be responsible for this link.
Researchers found that capsaicin, a compound in red chili pepper, exhibited anticancer activity against pancreatic cancer cells. Phenethyl isothiocyanate (PEITC), a constituent of cruciferous vegetables like broccoli, also showed therapeutic benefits in inhibiting ovarian cancer cell growth.
A new study found that altering food schedules and light/dark exposure in mice modified the expression of circadian clock genes and genes involved in carcinogenesis and tumor progression. The authors conclude that the altered light/dark or feeding schedules may slow tumor growth in chronic jet-lagged mice.
A Harvard School of Public Health study analyzed dietary habits and found no strong association between western or prudent diets and pancreatic cancer risk. Participants who adhered to the prudent diet had healthier lifestyle behaviors, suggesting individual dietary components may still play a role in risk.
Researchers at Mayo Clinic discovered a new pathway against pancreatic cancer by targeting the GSK-3 Beta molecule, which regulates NF Kappa B activity. This finding may lead to new drug development strategies for other cancers and improve treatment options for pancreatic cancer patients.
Researchers are evaluating the effectiveness of BAY43-9006 alone and paired with gemcitabine in a phase II clinical trial for metastatic pancreatic carcinoma. The trial aims to add much-needed treatment options for this aggressive cancer, which affects approximately 27,000 deaths annually in the US.
A recent study published in Annals of Internal Medicine found that high-quality CT scans can accurately determine which pancreatic cancers are treatable, rendering endoscopic ultrasound unnecessary. The study also revealed that CT scans were more accurate in detecting new cancers and determining the stage of the disease.
Researchers found that patients with a family history of pancreatic cancer are more likely to be diagnosed at an earlier age and have a smoking history. The study suggests that strong counseling against smoking is necessary for these patients, as well as smoking cessation programs.
Researchers at Université de Montréal found that diabetes patients are three times more likely to develop liver cancer and twice as likely to get pancreatic cancer. The study analyzed data from over 3,000 cancer patients and healthy individuals.
Researchers found a three-fold increased risk of liver cancer among diabetic patients, which rose to almost four-fold when medication was used. Diabetes did not increase risks for other types of cancer, such as melanoma or colon cancer.
Researchers have made significant progress in developing a therapeutic vaccine for pancreatic cancer, which appears safe and stimulates immune activity. In a recent study, 12 patients with pancreatic cancer received the vaccine, resulting in no reported toxicity and positive changes in antibodies against the tumor.
Cohen's team found that fibroblast activation protein (FAP) and focal adhesion kinase (FAK) are overexpressed in over 90% of pancreatic adenocarcinomas, suggesting they may contribute to poor outcomes. However, selective inhibition of these proteins shows promise in preclinical models.
A study of 138,307 men found exclusive pipe smoking increased risk for six cancers and three diseases, with highest risk in larynx, lung, and oropharynx. Pipe smoking was associated with smaller but similar risks to cigar smoking, while larger than cigarette smoking.
Researchers from Michigan Medicine have discovered a protein biomarker and cell-signaling pathway that may aid in the detection and treatment of pancreatic cancer. The study found that a specific protein called CEACAM 1 is elevated in the blood of pancreatic cancer patients, allowing for better differentiation from normal tissue.
Researchers have made breakthroughs in understanding the molecular mechanisms driving pancreatic cancer's rapid growth and resistance to treatment. They've identified new targets for therapy, including a protein sponge that suppresses tumor growth and a novel mechanism for chemoresistance.
Researchers found that administering opioid growth factor (OGF) to patients with advanced pancreatic cancer improved their quality of life and survival rates. OGF was shown to be non-toxic and did not cause common side effects associated with chemotherapy, such as hair loss or nausea.
A study found that the anti-inflammatory drug nimesulide triggered angiogenesis and increased pancreatic cancer cell growth in COX-2 negative tumor cells, but inhibited tumor growth in COX-2 positive cells. Researchers plan to test other COX-2 inhibitors for similar effects.
A Mayo Clinic study of 100 patients with advanced pancreatic cancer found that a nerve block technique, combined with pain-relieving medications, provided a 50% reduction in pain and improved quality of life. The study suggests that this treatment option could be beneficial for patients with pancreatic cancer, allowing them to live mor...
A study of over 88,000 women found no significant difference in pancreatic cancer risk between aspirin users and non-users. However, extended regular aspirin use was associated with a 58% increased risk, while higher doses were linked to an 86% increased risk.
A new animal model of pancreatic cancer has been developed, which mimics both non-invasive and invasive forms of the disease. The study identified a unique protein signature in the blood of animals with precancerous lesions, offering potential for early detection and therapeutic targets.
Researchers have developed a mouse model that mimics human pancreatic cancer, enabling the discovery of biomarkers for early detection and potential therapeutic targets. The model replicates the disease's progression and is poised to facilitate rapid testing of novel treatments.
Researchers have made significant progress towards a vaccine for pancreatic cancer, with one patient out of ten remaining disease-free after five years and two others surviving over two years. While the study's findings are promising, caution is advised due to the small sample size and potential biases in the selection process.
Researchers found that pancreatic cancer growth can be arrested by blocking the Hedgehog signaling pathway, which is active in human embryonic development. This pathway has been linked to several other types of cancer and may offer a new treatment avenue for pancreatic cancer.
Researchers at Johns Hopkins Medicine found that pancreatic cancer may be triggered by the reactivation of a growth signal normally turned off in adult tissues. By blocking this pathway, they hope to prevent the early cellular changes leading to cancer.
Researchers at Michigan Medicine have identified 158 genes specific to pancreatic cancer in a new study, providing a more accurate accounting of the disease's molecular makeup. The team hopes to use this knowledge to develop new diagnostic tests and treatments tailored to individual patients.
Researchers have identified a genetic link between Fanconi's Anemia and pancreatic cancer, finding that faulty FA-related genes can make cancer cells susceptible to certain treatments. This discovery may lead to improved treatment options for patients with early-onset pancreatic cancer caused by gene mutations.
Researchers identified BRCA2 germline mutations in 19% of families with familial pancreatic cancer. The presence of specific frameshift mutations was found in 12% of the families studied. These findings suggest an important role for BRCA2 mutations in a subpopulation of families with familial pancreatic cancer.
A study suggests that a high-starch diet may increase the risk of pancreatic cancer in overweight and sedentary women. Women with diets heavy in starchy foods were found to be more than two-and-a-half times more likely to develop pancreatic cancer than those with low glycemic loads.
A study found no association between carbohydrate and sucrose intake and pancreatic cancer risk, but a diet high in glycemic load increased the risk among overweight women. Dairy product consumption was not associated with reduced breast cancer risk among postmenopausal women, but may be protective in premenopausal women.
Researchers found that MMP-9 expression contributes to angiogenesis in human ovarian tumors, while dense breasts compromise diagnostic mammography sensitivity. Aspirin users have a lower risk of developing pancreatic cancer, according to the study.
A study of over 7 years found that women taking aspirin two to five times per week had a lower risk of pancreatic cancer compared to those not taking it. The researchers estimate that aspirin use might prevent up to 43% of pancreatic cancer cases in women who do not normally take aspirin.
The study demonstrated that gemcitabine was well-tolerated in patients with superficial bladder cancer, with no or very low levels of the drug found in plasma samples. The results suggest that gemcitabine may be a suitable alternative to current standard treatments, which often cause toxic side effects.
Researchers have identified a region of chromosome 4 associated with pancreatic cancer, which may lead to earlier identification and treatment. The discovery has potential implications for understanding the disease's causes and developing new treatments.
A large family study identified a specific genetic marker on chromosome 4 associated with inherited pancreatic cancer. The discovery sheds light on the disease's development and may lead to new prevention and treatment strategies.
African-American patients with non-small-cell lung cancer have a significantly lower one-year survival rate compared to non-African-American patients. Despite similar disease stages and health care disparities, researchers found no difference in outcomes after adjusting for factors such as performance status and socioeconomic status.
Researchers investigate DNA repair capacity and its association with melanoma risk, while also exploring the predictive value of HPV testing in managing equivocal Pap tests. Additionally, a study on breast cancer biomarkers finds that measuring uPA and PAI-1 levels may help predict disease course and inform treatment strategies.
Researchers at Columbia University Irving Medical Center have discovered a combination of two genes that selectively kill pancreatic cancer cells in test tube experiments. The mda-7 protein and K-ras antisense DNA combination prevents tumor growth in animals, offering a potential new treatment option for this aggressive disease.
A clinical trial found that marimastat produced comparable one-year survival rates to chemotherapy drug gemcitabine in patients with localized pancreatic cancer. Fewer toxic side effects were reported in patients taking marimastat compared to gemcitabine.
A long duration of regular aspirin use is associated with a significant increase in pancreatic cancer risk among women. Women taking 14 or more tablets per week experience nearly an 86% increased risk, while those taking six to 13 tablets per week see a 41% higher risk.
A new pancreatic cancer vaccine has been found to be safe and successful in reaching immune system cells, with several patients remaining disease-free over 30 months after diagnosis. The vaccine uses lab-grown pancreatic cancer cells genetically-modified with the immune-boosting gene GM-CSF.
A new study by Northwestern University Medical School researchers found that high blood sugar levels are associated with an increased risk of pancreatic cancer death. The study analyzed data from nearly 40,000 men and women who were screened for cardiovascular disease risk and followed up for an average of 25 years.
The Seattle Gastrointestinal Program Project will investigate the role of oxidative damage in pancreatitis and chronic ulcerative colitis. Researchers aim to develop screening tests for pancreatic cancer and more sensitive early detection methods for colon cancer.
Researchers found that tumors with a specific BRCA2 mutation are more sensitive to radiation and certain chemotherapy drugs. This suggests genetic screening could be used to tailor treatment for patients with this mutation, potentially improving outcomes.